Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICCC | US
0.09
0.94%
Healthcare
Biotechnology
30/06/2024
08/06/2026
9.70
9.61
9.99
9.61
ImmuCell Corporation an animal health company develops manufactures and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense a passive antibody product for the treatment of E. coli coronavirus and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk as well as to determine which quarter of the udder is mastitic; and Dual-Force First Defense including a whey protein concentrate for the nutritional and feed supplement markets. In addition it is involved in developing Re-Tain a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland Maine.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
58.9%1 month
67.1%3 months
57.3%6 months
51.5%-
-
1.23
0.68
0.38
-21.19
1.87
-
-633.70K
75.98M
75.98M
-
-25.34
-63.40
54.90
-16.10
0.20
0.18
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.46
Range1M
2.63
Range3M
4.75
Rel. volume
0.65
Price X volume
201.90K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Common Stock | TARA | Biotechnology | 4.04 | 83.34M | -2.88% | n/a | 5.41% |
| ALXO | ALXO | Biotechnology | 1.57 | 82.69M | 1.95% | n/a | 10.97% |
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 5.86 | 82.60M | 1.03% | n/a | 81.86% |
| Fortress Biotech Inc | FBIO | Biotechnology | 2.85 | 78.56M | 7.55% | n/a | 494.61% |
| NextCure Inc | NXTC | Biotechnology | 2.79 | 78.05M | -5.42% | n/a | 7.21% |
| vTv Therapeutics Inc | VTVT | Biotechnology | 32.06 | 78.00M | -0.25% | n/a | 1.55% |
| iShares MSCI Brazil ETF USD Acc | CSBR | Biotechnology | 5.64 | 76.67M | -0.18% | n/a | -2140.66% |
| XBiotech Inc | XBIT | Biotechnology | 2.37 | 72.20M | 0.00% | n/a | 5.08% |
| Tenaya Therapeutics Inc. Common Stock | TNYA | Biotechnology | 0.6864 | 70.11M | -5.73% | n/a | 11.62% |
| Pliant Therapeutics Inc. | PLRX | Biotechnology | 1.15 | 69.92M | 0.00% | n/a | 15.34% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 3.6121 | 65.23M | 3.20% | n/a | 5.48% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 6.08 | 57.88M | 3.58% | n/a | 19.98% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 8.97 | 56.17M | -0.88% | 14.48 | 7.10% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.08 | 32.10M | -0.02% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.1 | 16.07M | 7.84% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4131 | 7.98M | -3.48% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | 12.88% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.19 | 0.53 | Cheaper |
| Ent. to Revenue | 1.87 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.23 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 57.28 | 72.80 | Lower Risk |
| Debt to Equity | 0.68 | -1.23 | Expensive |
| Debt to Assets | 0.38 | 0.25 | Expensive |
| Market Cap | 75.98M | 3.66B | Emerging |